Workflow
摩享时光共享按摩椅
icon
Search documents
调研速递|奥佳华接待山西证券等1家机构调研 聚焦战略规划及4.58亿元可转债转股情况
Xin Lang Cai Jing· 2025-11-07 13:55
关于"摩享时光"共享按摩椅品牌的发展情况,奥佳华表示,将坚持轻资产业务模式,持续升级产品与服 务体系。国内市场方面,继续扩大万达、华润万象城等中高端商场渠道覆盖,重点布局一二线大城市, 并加快推进三四线下沉市场开拓规划落地;海外市场则聚焦东南亚、中东等潜力区域,逐步增加优质网 点布局。可转债转股情况:剩余余额4.58亿元,未来六个月不下修转股价 互动交流核心要点未来发展战略:深耕大健康产业,聚焦三大方向 针对"公司未来发展战略是否有变动"的问题,奥佳华表示,公司将立足当下谋划长远,持续深耕大健康 产业,聚焦保健按摩核心主业。具体来看,战略方向包括三方面:一是以自主品牌业务为发展基石,精 耕东亚、东南亚、北美等按摩产品核心市场,同时积极开拓新兴市场,通过推出贴合需求的高品质产品 及服务提升品牌竞争力;二是坚持科技创新,围绕"AI+"技术重点加大研发投入,推动产品智能化升 级,扩大核心技术领先优势;三是持续推进经营拓新、制造提效及国际化生产布局,增强公司经营韧 性。健康环境业务:深化北美合作,拓展日韩台市场并强化供应链 在健康环境业务单元发展规划方面,公司介绍,该板块将紧跟市场变化,加快产品创新及品质提升。一 方 ...
奥佳华(002614) - 2025年11月7日投资者关系活动记录表
2025-11-07 13:16
证券代码:002614 证券简称:奥佳华 投资者关系活动记录表 4、公司可转债转股情况如何?公司是否会下修调整可转债转 股价? 截至 2025 年 9 月 30 日,"奥佳转债"剩余可转债余额为 458,257,200.00 元(4,582,572 张)。公司于 2025 年 7 月 4 日召 开第六届董事会第九次会议,审议通过了《关于不向下修正"奥 佳转债"转股价格的议案》,公司董事会决定本次以及在未来六 个月内(即 2025 年 7 月 5 日至 2026 年 1 月 4 日)不向下修正"奥 佳转债"转股价格。未来若"奥佳转债"再次触发下修条件,届 时公司董事会将召开会议决定是否行使"奥佳转债"转股价格向 下修正权利。 5、公司的销售费用和销售收入挂钩吗,每年保持一定销售 收入占比吗? 编号:2025-06 投资者关系活动 类别 √ 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 参与单位名称及 人员姓名 山西证券:陈玉卢 时间 2025 年 11 月 7 日(周五)下午 13:30 地点 厦门市湖里区安岭二路 31-37 号 8 楼 上市 ...
奥佳华(002614) - 2025年9月17日至9月18日投资者关系活动记录表
2025-09-18 11:02
Group 1: Company Overview and Business Segmentation - The company operates in health products, including massage chairs (44.23%), small massage appliances (30.64%), health environment products (15.30%), and others (9.83%) as of the first half of 2025 [2][3]. - The company has a clear long-term strategy focused on the health industry, with over 50% of revenue coming from its own brand in the first half of 2025 [4]. Group 2: Market Trends and Industry Insights - The massage equipment industry is influenced by cultural acceptance in East and Southeast Asia, as well as increasing recognition in North America and Europe [3]. - The domestic market for massage health products has low penetration and concentration, indicating significant growth potential due to rising health demands and an aging population [3]. Group 3: Financial Performance and Challenges - The company has faced declining revenue and net profit due to global economic slowdown and weak consumer demand [4]. - Despite market pressures, the company reported a 15.97% increase in revenue and a 425.71% increase in net profit for the "OGAWA" brand in China during the first half of 2025 [4]. Group 4: Marketing and Brand Strategy - The company emphasizes continuous investment in its own brand to enhance market control and brand value [5]. - Marketing strategies include targeted promotions in major cities, leveraging social media, and collaborating with influencers to boost brand visibility [5]. Group 5: Product Innovation and Technology - The company leads the industry with its globally innovative 5D core technology, enhancing product performance through AI integration [7][8]. - The company is also developing intelligent health service robots based on traditional Chinese medicine principles, aligning with national health strategies [8]. Group 6: Production and Supply Chain Management - The company has established a production base in Vietnam with an annual capacity of 5.4 million units for small health appliances, enhancing its global supply chain resilience [6]. - The company plans to dynamically adjust production based on market demand and international conditions [6]. Group 7: Convertible Bonds and Financial Management - As of June 30, 2025, the remaining balance of "OGAWA convertible bonds" is 458 million yuan, reclassified as current liabilities due to upcoming maturity [8]. - The board decided not to lower the conversion price of the convertible bonds for the next six months, with future adjustments contingent on market conditions [8].